Jump To:
Search:
 

ePrescribing

ePrescribing provides you with a simple, powerful, and fast method to send patient medical prescriptions electronically to pharmacies. If you are using an ePrescribing system to meet EHR Incentive Program meaningful use CPOE, drug-drug and drug-allergy interaction check, and drug formulary check requirements and to generate and transmit permissible prescriptions electronically, it must be a “qualified” eRx system. There are two types of systems: a system for eRx only (standalone) and an electronic health record with eRx functionality (ExamWRITER ePrescribing Interface). If you are not participating in the EHR Incentive Program, you can use a “qualified” eRx system to qualify for a 1% incentive payment in 2011 and 2012 and a 0.5% incentive payment in 2013 and beyond.

Eyefinity highly recommends that you use the ExamWRITER ePrescribing Interface as your qualified ePrescribing system because it is an integrated solution between ExamWRITER and DrFirst and without it, you will
not be able to report your ePrescribing system use for the EHR Incentive Program from within OfficeMate/ExamWRITER, you will have to manually calculate your EHR Incentive Program meaningful use percentages, and you will also have to rerecord prescriptions that you recorded in ExamWRITER in the standalone system.

To begin qualifying for meaningful use and earning your incentives, start writing and transmitting your prescriptions using the ExamWRITER ePrescribing Interface. To receive the full benefits of ePrescribing and ensure smooth workflow in your office, use the ExamWRITER ePrescribing Interface to write prescriptions for all patients, not just Medicare patients. The Centers for Medicare and Medicaid (CMS) will measure your ePrescribing activity through the billing codes you submit to Medicare.

Note that the CMS has indicated that optometrists, unlike ophthalmologists and most other physicians, will not be subject to a 1.5% ePrescribing penalty in 2011 if they do not submit ten out of 25 prescriptions via an ePrescribing system prior to June 30, 2011. Although optometrists will not be subject to the Medicare ePrescribing penalty in 2011, they can avoid penalties in subsequent years by starting ePrescribing now. The AOA recommends members have a plan for ePrescribing and look into ways to do ePrescribing in 2011 even if they are implementing EHRs in 2012 or beyond. CMS officials have suggested that they will impose penalties of 1.5% on optometrists in 2012 and 2% on optometrists in 2013–2018, based on performance in 2011 and beyond.

The requirements to participate in the incentive program are very straight forward. There are three steps:

  1. Sign up qualified ePrescribing system like the ExamWRITER ePrescribing Interface.
  2. Record G-Code G8553 on your fee slip so that it is submitted via the CMS 1500 form or X12 837 claim file to the CMS (90801-9; 90862; 92002; 92004; 92012; 92014; 96150-2; 99201-5; 99211-5; 99304-10; 99315-16; 99341-5; 99347-50; G0101; G0108-9).
  3. Ensure that you have at least 25 ambulatory visits and other applicable services for applicable CPT codes.

In addition to providing you with Medicare financial incentives, ePrescribing includes the following features and benefits:

  • Drug/drug, drug/allergy interaction checking, dosage alerts, and other clinical decision tools
  • Real-time patient medication lists are pulled from three Pharmacy Benefit Management (PBM) systems and the pharmacy fill history
  • Patient-specific formulary statuses are displayed at the point of care
  • Connectivity to Caremark, ES, and Medco
  • Ability to split prescriptions to both retail and mail order pharmacies
  • One-click renewal process
  • Fewer calls from pharmacies and potential adverse drug events
  • Increased on-formulary prescriptions
  • Faster patient notification in the event of FDA safety alerts
  • Fewer handwriting interpretation errors
  • Increased productivity due to less time spent with pharmacy questions and renewal requests

For More Information

For more information on the ExamWRITER ePrescribing Interface, contact Eyefinity today at 800.269.3666 or sales@eyefinity.com.